Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome (Q71997331)
Jump to navigation
Jump to search
scientific article published on 01 July 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome |
scientific article published on 01 July 1994 |
Statements
Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome (English)
E J Bow
M G Kilpatrick
B A Scott
J J Clinch